Cargando…

Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset

Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underl...

Descripción completa

Detalles Bibliográficos
Autores principales: Power, Melinda C., Willens, Victoria, Prather, Christina, Moghtaderi, Ali, Chen, Yi, Gianattasio, Kan Z., Grodstein, Francine, Shah, Raj C., James, Bryan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666707/
https://www.ncbi.nlm.nih.gov/pubmed/38026091
http://dx.doi.org/10.1177/23337214231213185
_version_ 1785148989507633152
author Power, Melinda C.
Willens, Victoria
Prather, Christina
Moghtaderi, Ali
Chen, Yi
Gianattasio, Kan Z.
Grodstein, Francine
Shah, Raj C.
James, Bryan D.
author_facet Power, Melinda C.
Willens, Victoria
Prather, Christina
Moghtaderi, Ali
Chen, Yi
Gianattasio, Kan Z.
Grodstein, Francine
Shah, Raj C.
James, Bryan D.
author_sort Power, Melinda C.
collection PubMed
description Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underlying cited risks and benefits of receiving a diagnosis around the time of dementia onset, including impacts on physical health, impacts on mental health, care partner interactions, costs of care, increased time for care planning, or earlier access to treatment. While various groups continue to push for reductions in diagnostic delay, realization of benefits and mitigation of harms will require new research on potential benefits and harms. Workforce and resource constraints, coupled with the expected growth in the number of persons living with dementia, may be a barrier to realization of potential benefits and mitigation of identified harms, which will require adequate access to providers, services, and supports.
format Online
Article
Text
id pubmed-10666707
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106667072023-11-22 Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset Power, Melinda C. Willens, Victoria Prather, Christina Moghtaderi, Ali Chen, Yi Gianattasio, Kan Z. Grodstein, Francine Shah, Raj C. James, Bryan D. Gerontol Geriatr Med Article Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underlying cited risks and benefits of receiving a diagnosis around the time of dementia onset, including impacts on physical health, impacts on mental health, care partner interactions, costs of care, increased time for care planning, or earlier access to treatment. While various groups continue to push for reductions in diagnostic delay, realization of benefits and mitigation of harms will require new research on potential benefits and harms. Workforce and resource constraints, coupled with the expected growth in the number of persons living with dementia, may be a barrier to realization of potential benefits and mitigation of identified harms, which will require adequate access to providers, services, and supports. SAGE Publications 2023-11-22 /pmc/articles/PMC10666707/ /pubmed/38026091 http://dx.doi.org/10.1177/23337214231213185 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Power, Melinda C.
Willens, Victoria
Prather, Christina
Moghtaderi, Ali
Chen, Yi
Gianattasio, Kan Z.
Grodstein, Francine
Shah, Raj C.
James, Bryan D.
Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
title Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
title_full Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
title_fullStr Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
title_full_unstemmed Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
title_short Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
title_sort risks and benefits of clinical diagnosis around the time of dementia onset
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666707/
https://www.ncbi.nlm.nih.gov/pubmed/38026091
http://dx.doi.org/10.1177/23337214231213185
work_keys_str_mv AT powermelindac risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT willensvictoria risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT pratherchristina risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT moghtaderiali risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT chenyi risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT gianattasiokanz risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT grodsteinfrancine risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT shahrajc risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset
AT jamesbryand risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset